ManageCare transforms interstitial lung disease care with patient journey orchestration that addresses the diagnostic complexity and treatment monitoring intensity this specialty demands. From processing referrals with HRCT and PFT data to coordinating multidisciplinary discussion, antifibrotic therapy monitoring, and transplant evaluation, our AI ensures patients progress through care without delays.
Orchestrate the ILD journey — from referral through multidisciplinary diagnosis, antifibrotic therapy, and lung health surveillance
74%
Reduction in time from referral to multidisciplinary diagnosis
91%
Antifibrotic therapy monitoring compliance
62%
Decrease in diagnostic lung biopsy rates via improved HRCT-clinical correlation
2.6x
Improvement in early transplant referral rates
ILD patients face one of medicine's most complex diagnostic pathways — referrals lack pulmonary function and imaging data, multidisciplinary discussion scheduling delays diagnosis by months, antifibrotic therapy requires close monitoring for hepatotoxicity and GI intolerance, and transplant evaluation coordination is entirely manual.
Referrals arrive without HRCT images, PFT reports, or exposure history — requiring weeks of data gathering before evaluation
Multidisciplinary discussion requires coordination of pulmonology, radiology, pathology, and rheumatology schedules
Antifibrotic medications cause GI side effects and hepatotoxicity requiring frequent monitoring that is inconsistently tracked
PFT decline trends are only visible when serial data is compiled and analyzed — which rarely happens proactively
Transplant evaluation involves coordination across 10+ subspecialties with no automated workflow management
Patients with progressive fibrosis need escalating oxygen support that is not monitored between visits
Every workflow purpose-built for interstitial lung disease operations.
Referral intake with OCR extraction, patient matching, and insurance verification in under 3 minutes — extracting HRCT patterns, pulmonary function trends, autoimmune serologies, and occupational/environmental exposure history
AI-driven scheduling matching patients to optimal slots based on disease progression urgency, multidisciplinary discussion coordination, PFT lab availability, and antifibrotic monitoring intervals
Smart waitlist that fills cancellations within minutes via automated SMS and voice outreach — prioritizing patients with rapidly declining FVC, acute exacerbations, or pending transplant evaluations
Pre-treatment prep automation — PFT scheduling, HRCT coordination, autoimmune panel ordering, medication hepatotoxicity consent, and occupational exposure questionnaire delivery with compliance confirmation
Multi-channel patient engagement: reminders, confirmations, and prep instructions via SMS, voice, and portal — including supplemental oxygen education, antifibrotic side effect monitoring, and pulmonary rehab coordination
Real-time pulmonary function trend monitoring with AI severity assessment and escalation — tracking FVC decline rate, DLCO trends, 6-minute walk test results, and oxygen requirement changes
Post-treatment AI triage with 91% first-call resolution — addressing antifibrotic GI side effects, oxygen titration questions, dyspnea management, and acute exacerbation symptom screening
Automated ILD surveillance and follow-up — zero patients lost to follow-up with scheduled PFTs, imaging, liver function monitoring, and transplant readiness assessments at protocol-defined intervals
Specialized AI employees that handle these workflows autonomously.
Processes ILD referrals by extracting HRCT patterns (UIP, NSIP, etc.), PFT trends, autoimmune serologies, and environmental exposure history. Compiles multidisciplinary discussion-ready case summaries and flags rapidly progressive cases for urgent evaluation.
Coordinates complex diagnostic pathways including PFT scheduling, HRCT timing, multidisciplinary discussion slots, and bronchoscopy if needed. Manages antifibrotic monitoring visit cadence and fills cancellations prioritizing patients with accelerated FVC decline.
Delivers ILD-specific education including supplemental oxygen training, antifibrotic medication guidance, and pulmonary rehabilitation coordination via SMS, voice, and portal. Tracks medication adherence, side effect reporting, and oxygen usage to maintain engagement between visits.
Monitors PFT trajectories and functional status trends with AI-powered FVC decline prediction. Provides triage with 91% first-call resolution for dyspnea management, antifibrotic side effects, and oxygen concerns, escalating acute exacerbations and critical FVC decline for immediate intervention.
Learn more about the platform, AI employees, and measurable outcomes powering modern healthcare practices.
See the autonomous agents that handle scheduling, referrals, care management, and more.
Learn MoreUnderstand the architecture, integrations, and security behind ManageCare.
Learn MoreDiscover solutions for scheduling, waitlists, prior auth, patient outreach, and beyond.
Learn MoreExplore how practices reduce scheduling delays, increase throughput, and cut referral leakage.
Learn MoreSee how ManageCare's AI employees can automate your most time-consuming workflows and unlock new revenue.